| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1B | $5.3B | $5.2B | $4.9B | $4.4B | $1.1B | $1.1B | $1.2B |
| Cost of Revenue | $3.4B | $3.5B | $3.6B | $3.5B | $3.0B | $0.7B | $0.7B | $0.8B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $0.8B | $0.8B | $0.8B | $0.8B | $0.7B | $0.7B | $0.8B | $1.0B |
| Operating Income | $0.7B | $0.7B | $0.6B | $0.4B | $0.5B | $0.2B | $0.1B | $0.1B |
| Net Income | $0.4B | $0.4B | $0.3B | $0.2B | $0.3B | $0.1B | $0.0B | $0.1B |
| EPS (Basic) | $1.75 | $1.78 | $1.21 | $0.86 | $1.14 | $0.30 | $0.18 | $0.32 |
| EPS (Diluted) | $1.74 | $1.78 | $1.21 | $0.86 | $1.14 | $0.30 | $0.18 | $0.32 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.6B | $7.2B | $7.3B | $7.1B | $7.2B | $7.2B | $6.8B | $6.7B |
| Current Assets | $2.8B | $2.7B | $2.8B | $2.7B | $2.6B | $2.9B | $2.6B | $2.3B |
| Cash & Equivalents | $0.7B | $0.6B | $0.7B | $0.6B | $0.8B | $1.4B | $1.0B | $0.7B |
| Total Liabilities | $5.2B | $5.3B | $5.5B | $5.6B | $5.7B | $5.7B | $5.4B | $5.4B |
| Current Liabilities | $1.4B | $1.4B | $1.4B | $1.4B | $1.3B | $1.2B | $1.1B | $1.0B |
| Stockholders' Equity | $2.3B | $1.9B | $1.7B | $1.5B | $1.5B | $1.4B | $1.4B | $1.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.6B | $0.6B | $0.3B | $0.6B | $0.5B | $0.6B | — |
| Investing Cash Flow | $-0.2B | $-0.4B | $-0.2B | $-0.1B | $-0.7B | $-0.1B | $-0.1B | — |
| Capital Expenditures | $0.2B | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.4B | $-0.2B | $-0.3B | $-0.4B | $-0.3B | $-0.1B | $-0.2B | — |